bpc 157 hsa eligible BPC-157 PURE Delayed Release Peptide Therapy Clinic Tarzana |
Description
The combination has not been studied as a single formulation in clinical trials
In rodents, BPC-157s plasma half-life was close to 4 hours after intraperitoneal injection
Kolovrat et al., 2020), BPC 157 is known to reduce lesions in the entire gastrointestinal tract (Sikiric et al., 1994
Tesamorelin has some of the strongest evidence for specifically reducing visceral abdominal fat
Expect to experience all the benefits of the injections within about 2-3 weeks
